CRC cells treated with S100A9 produced more ROS and Nox4, which enhanced the stemness of CSCs by inducing the phosphorylation levels of STAT3 and NF-κB p65 [162] (Fig. 6D). This evidence concerns the gene S100A9 and colorectal carcinoma.